Navigation Links
Jazz Pharmaceuticals to Present at Lazard Healthcare Conference
Date:11/15/2007

PALO ALTO, Calif., Nov. 15 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Robert Myers, the company's President, will provide a corporate presentation at the Lazard Capital Markets 4th Annual Healthcare Conference in New York, NY on November 28, 2007 at 11:00 a.m. Eastern Time.

A live webcast of the presentation may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website until December 12, 2007.

About Jazz Pharmaceuticals, Inc. Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

For further information see http://www.JazzPharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... Arete Therapeutics Inc., a,privately-held biotec...epoxide,hydrolase (s-EH) inhibitors, today announ...eries A financing. Frazier Healthcare Ventures and...which also included existing,investors Burrill &a...e Science,Ventures. This financing completes the...
(Date:11/19/2008)...wire-FirstCall/ -- In a campaign,to significantly...omen, the,Mexican Public Health Agency (Secretari...the first phase of a program that will offer testi...use of cervical cancer, to low-income,women age 3...he agency. In,the first phase of the screening pr...
(Date:11/18/2008)... Genesis, Inc., an innovator of,advanced tissue e...nced that,effective immediately, the Tissue Genes... European marketplace. , The Tissue Genesis... that,recovers potentially regenerative cells fro...mal operator intervention. No tissue pre-processin...
(Date:11/18/2008)...launches an online marketplace dedicated to connec...hrough a confidential listing service. TechMandA.c...es targeted access to buyers and sellers of techno... Atlanta, GA (PRWEB) Novem...n online marketplace dedicated to connecting buyer...
Breaking Biology Technology:Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing 2Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 2Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 3Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 4Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 5Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System 2Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System 3Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System 4Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System 5TechMandA.com Marketplace Streamlines M&A Process for Technology Businesses 2TechMandA.com Marketplace Streamlines M&A Process for Technology Businesses 3
...n, Mass . - Actors turned activists, researchers w...ossibility record-setting attendance are part of t...haps no geographic region is more eager to tell it...he news that Quincy Bioscience , a Madison-based ...compound for the treatment of strokes. , ,The high...
...osse, Wis . - Logistics Health, Inc ., a provider...al organizations, has established a Web-based opti...r health-related compliance programs. , ,In the an...al Health Conference in New Orleans, Logistics He...nagement Optimization, according to Insurance New...
...on, Wis .- TomoTherapy has raised $223 million, ...blic offering that was completed earlier today. , ...e Partners I , offered common stock at $19 per sha...ceeds after transaction costs are deducted. , ,Tra...hare price closed at $22.67. , ,According to a reg...
...on, Wis. - Eight private-sector members have been...ormation Technology Failures, joining eight public...bly Speaker Mike Huebsch, R-West Salem, and State ...ollowing appointments: , ,Tom Andreoli, CIO, Schr...anager, Business Objects , La Crosse; Steven Haro...
Other Biology Technology:BIO 2007: Wisconsin makes its presence felt 2BIO 2007: Wisconsin makes its presence felt 3BIO 2007: Wisconsin makes its presence felt 4TomoTherapy raises $223 million in IPO 2Speaker announces business members of IT Task Force 2
(Date:11/19/2008)...f researchers at Carnegie Mellon University,s Robo...n in grants from the U.S. Department of Agricultur...s for apple growers and one is for orange growers,...d lower production costs. , The systems use sens...es within the orchards to gather a multitude of da...
(Date:11/19/2008)...eered trachea (windpipe), utilising the patient,s ... into a young woman with a failing airway. The bio...t with a normally functioning airway, thereby savi... crucial new evidence that adult stem cells, combi...fer genuine solutions to other serious illnesses. ...
(Date:11/19/2008)...s news of an apparent breakthrough against cancer,... diabetes, but these rarely translate into effecti...l development usually takes well over a decade. On...highly fragmented groups focusing on specific path...not to work properly or to have dangerous side eff...
(Date:11/19/2008)...eated by a University of Central Florida professor...umors. , Associate Professor James Turkson,s com...cancer tumors in tests on mice. The compounds, S3...tein called STAT3, and researchers have observed n... are very promising," Turkson said. "They,ve worke...
Breaking Biology News(10 mins):Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 3Adult stem cell breakthrough 2Adult stem cell breakthrough 3Systems biology brings hope of speeding up drug development 2Systems biology brings hope of speeding up drug development 3Two new compounds show promise for eliminating breast cancer tumors 2American Cancer Society report finds breast cancer death rate continues to drop 1975 1American Cancer Society report finds breast cancer death rate continues to drop 1975 2American Cancer Society report finds breast cancer death rate continues to drop 1975 3American Cancer Society report finds breast cancer death rate continues to drop 1975 4New book presents successful strategies for probing genetic variation 553 1New book presents successful strategies for probing genetic variation 553 2New book presents successful strategies for probing genetic variation 553 3Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 1971 1Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 1971 2Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens 1967 1Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens 1967 2
... second counts. Yet bruises, burns, and other phys...veins and administer lifesaving drugs or solutions...chnology researchers is developing an inexpensive,...nology to find veins quickly. , "Depth and angle...ys project leader Michael Gray, a research enginee...
...ich the abnormal activity of the dopamine machiner... and behavioral impairments mimicking those in hum... because creating an animal model of any schizophr... schizophrenia,s genetic and physiological complex...d the disorder. , Dr.s Christoph Kellendonk, Elea...
...ating kidney disease, report scientists at the Uni...e the discovery in the online edition of the Proce...hed the week of March 20. , The drug is rapamycin,...n immunosuppressant, to help prevent rejection of...le in the U.S., and 12 million worldwide, are affe...
...h spurt during the dry season, according to new re...Most of the vegetation around the world follows a ... during the rainy season and then during the dry s...r in the soil to support plant growth," said lead ...rizona in Tucson. , "What we found for a large se...
Other Biology News:Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Engineered mouse mimics cognitive aspects of schizophrenia 2Engineered mouse mimics cognitive aspects of schizophrenia 3Scientists discover that widely available drug also helps fight kidney disease 2Scientists discover that widely available drug also helps fight kidney disease 3Amazon rainforest greens up in the dry season 2Amazon rainforest greens up in the dry season 3
SphingoStripsTM contain fifteen different biologically active, nitrocellulose-immobilized lipids at 100 pmol per spot, which can be assayed for protein binding and specificity using a simple blot ove
RNA 6000 Nano Chip Kit from Agilent Technologies
Mouse monoclonal antibody raised against a partial recombinant KRT4. NCBI Entrez Gene ID = KRT4
Mouse monoclonal antibody raised against a partial recombinant ALPK3. NCBI Entrez Gene ID = ALPK3
Biology Products: